Saluda Medical competitors

Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.

Spinal & Peripheral Interfaces · IPO $89.6M

Spinal & Peripheral Interfaces

IPO

$89.6M

HQ

Develops peripheral nerve interfaces and implantable devices for prosthetic control and sensory feedback.

Spinal & Peripheral Interfaces · Series A $19M

Spinal & Peripheral Interfaces

Series A

$19M

HQ